A cryopreserved, amniotic placental tissue allograft

RHEO™ is a flowable amniotic placental tissue allograft. RHEO™ is aseptically processed using a proprietary minimally manipulated approach that retains the extracellular matrix and 3D collagen structure of its scaffold. It is combined with amniotic fluid, then cryopreserved to maintain the viability of the intercellular messengers. The allograft provides a natural collagen scaffold to support replacement by endogenous tissue.1 RHEO™ is intended for homologous use in the repair, replacement, reconstruction, or augmentation of human tissue.

Key Points

  • VEGF: 36.6± 3.2 pg per 1-mil

  • bFGF: 802± 34 pg per 1-mil

  • PDGF-BB: 38.7± 2.8 pg per 1-ml

  • IL-1ra: 13,015± 58 pg 1-mil

RHEO™ is available in 0.5, 1.0 and 2.0 mL sizes.
1 Olczyk P, Mencner Ł, Komosinska-Vassev K. The role of the extracellular matrix components in cutaneous wound healing. Biomed Res Int. 2014;2014:747584. doi:10.1155/2014/747584

To request general product information or for more specific questions, please feel free to contact us.